Prospects for new lung cancer treatments that target EMT signaling

研究成果: Review article

34 引用 (Scopus)

抜粋

Lung cancer is the most common cancer worldwide. Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, molecularly targeted therapy including epidermal growth factor receptor or anaplastic lymphoma kinase inhibitors, and immunotherapy. These treatments can be administered alone or in combination. Despite therapeutic advances, however, lung cancer remains the leading cause of cancer death. Recent studies have indicated that epithelial-mesenchymal transition (EMT) is associated with malignancy in various types of cancer, and activation of EMT signaling in cancer cells is widely considered to contribute to metastasis, recurrence, or therapeutic resistance. In this review, we provide an overview of the role of EMT in the progression of lung cancer. We also discuss the prospects for new therapeutic strategies that target EMT signaling in lung cancer. Developmental Dynamics 247:462–472, 2018.

元の言語English
ページ(範囲)462-472
ページ数11
ジャーナルDevelopmental Dynamics
247
発行部数3
DOI
出版物ステータスPublished - 2018 3 1

ASJC Scopus subject areas

  • Developmental Biology

フィンガープリント Prospects for new lung cancer treatments that target EMT signaling' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用